Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2023 - 04:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934
(Amendment No.)
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement
|
| ☐ |
Confidential, for Use of the Commission Only (as
permitted by Rule 14a-6(e)(2))
|
| ☐ |
Definitive Proxy Statement
|
| ☒ |
Definitive Additional Materials
|
| ☐ |
Soliciting Material under §240.14a-12
|
Homology Medicines, Inc.
(Name of Registrant as Specified in its
Charter)
(Name of Person(s) Filing Proxy Statement, if
Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☐ |
Fee paid previously with preliminary materials
|
| ☐ |
Fee computed on table in exhibit required by Item
25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Your Vote Counts! HOMOLOGY MEDICINES, INC.
2023 Annual Meeting Vote by June 13, 2023 11:59 PM ET HOMOLOGY
MEDICINES, INC. ONE PATRIOTS PARK BEDFORD, MA 01730 V15880-P88541
You invested in HOMOLOGY MEDICINES, INC. and it’s time to vote! You
have the right to vote on proposals being presented at the Annual
Meeting. This is an important notice regarding the availability of
proxy materials for the stockholder meeting to be held on
June 14, 2023. Get informed before you vote View the Notice
and Proxy Statement and Form 10-K online OR you can receive a free
paper or email copy of the material(s) upon request prior to
May 31, 2023. If you would like to request a copy of the
material(s) for this and/or future stockholder meetings, you may
(1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or
(3) send an email to sendmaterial@proxyvote.com. If sending an
email, please include your control number (indicated below) in the
subject line. Unless requested, you will not otherwise receive a
paper or email copy. For complete information and to vote, visit
www.ProxyVote.com Control # Smartphone users Vote Virtually at the
Meeting* Point your camera here and June 14, 2023 8:30 AM EDT
vote without entering a control number Virtually at:
www.virtualshareholdermeeting.com/FIXX2023 *Please check the
meeting materials for any special requirements for meeting
attendance. V1.2
Vote at www.ProxyVote.com THIS IS NOT A
VOTABLE BALLOT This is an overview of the proposals being presented
at the upcoming stockholder meeting. Please follow the instructions
on the reverse side to vote these important matters. Voting Items
Board Recommends 1. Election of Class II Directors to serve
until the 2026 Annual Meeting of Stockholders, and until their
respective successors shall have been duly elected and qualified.
Nominees: For 01) Steven Gillis, Ph.D. 02) Albert Seymour, Ph.D. 2.
Ratification of the appointment of Deloitte & Touche LLP
as our independent registered public accounting firm for the For
fiscal year ending December 31, 2023. NOTE: To transact such
other business as may properly come before the Annual Meeting or
any continuation, postponement, or adjournment of the Annual
Meeting. Prefer to receive an email instead? While voting on
www.ProxyVote.com, be sure to click “Delivery Settings”.
V15881-P88541
Homology Medicines (NASDAQ:FIXX)
Historical Stock Chart
From Sep 2023 to Oct 2023
Homology Medicines (NASDAQ:FIXX)
Historical Stock Chart
From Oct 2022 to Oct 2023
